Quick Summary:
In a fast-paced environment like the Neuroscience Antibodies and Assays market, remaining aware of trends, shifts, and emerging opportunities is critical for strategic decision-making. For senior business executives, our new global market research report is an essential tool. Our comprehensive study estimates that this buzzing market, currently valued at US$4.4 Billion, is projected to double and reach a revised size of US$8.8 Billion by 2030. It delivers meticulous analysis of market tendencies, providing you the information you need to stay competitive.
Moreover, understanding individual segment growth can be beneficial. For instance, the Consumables segment, analyzed in the report, is projected to record a 9.3% CAGR and reach US$5.9 Billion by the end of the analysis period. The US market is calculated at US$1.3 Billion, while powerhouse China is forecasted to trail with an 8.3% CAGR. This provides an extensive view of markets across the globe. Leverage this comparative analysis to identify strategic growth areas and potential risks.
Global Neuroscience Antibodies and Assays Market to Reach $8.8 Billion by 2030
The global market for Neuroscience Antibodies and Assays estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$8.8 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 9.3% CAGR and reach US$5.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 8.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 8.3% CAGR
The Neuroscience Antibodies and Assays market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.Select Competitors (Total 11 Featured) -
- Abcam PLC
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- F. Hoffmann-La Roche AG
- GenScript Biotech Corporation
- Merck KgaA
- Rockland Immunochemicals, Inc.
- Santa Cruz Biotechnology, Inc.
- Siemens Healthineers
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Neuroscience Antibodies and Assays?
What is the growth rate of the Global Market for Neuroscience Antibodies and Assays?
What is the forecasted size of the Global Market for Neuroscience Antibodies and Assays?
Who are the key companies in the Global Market for Neuroscience Antibodies and Assays?
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 4.4 Billion |
| Forecasted Market Value ( USD | $ 8.8 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abcam PLC
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- F. Hoffmann-La Roche AG
- GenScript Biotech Corporation
- Merck KgaA
- Rockland Immunochemicals, Inc.
- Santa Cruz Biotechnology, Inc.
- Siemens Healthineers
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
